Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15231719Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award categories
- Neurology
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#4,729
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $1.6M in linked award amounts across 2 award records · Award-linked rank #4729.
FY2026 award records by amount
NIH award records listing Amit Bar-or as a PI. Multi-PI records show the full award amount for context.
- 1U01AI195194-01U01AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis$1.3Maward amount
- 1R21AI193282-01A1R21Deep phenotyping of DR15-restricted CD4+ T cells specific for Epstein-Barr virus epitopes in the spinal fluid and blood of people with multiple sclerosis$247.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Amit Bar-or as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardUniversity of Pennsylvania
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #4729
- 2026Entered Top 25% NationallyRanked #4729
- 2026Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Amit Bar-or.